Structure and Expression of Translocated c-myc Oncogenes: Specific Differences in Endemic, Sporadic and AIDS-Associated Forms of Burkitt Lymphomas

  • Luisa Lanfrancone
  • Pier-Giuseppe Pelicci
  • Riccardo Dalla-Favera
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 132)


Burkitt lymphomas (BL) are characterized by reciprocal chromosomal translocations which involve the c-myc oncogene locus on chromosome 8 and immunoglobulin (Ig) loci on either chromosome 2, 14 or 22 (Dalla-Favera et al. 1982, 1983; Taub et al. 1982; Leder et al. 1983; Croce et al. 1985). The consistent occurrence of these specific recombination events in BL and the presence of analogous recombinations involving c-myc in similar tumors in other species (Sheng-Ong 1982), suggests that the c-myc gene plays a role in the pathogenesis of BL. Despite their remarkable similarity at the cytogenetic level, these translocation events are extremely heterogeneous at the molecular level. In this study we report that chromosomal breakpoints and structural alterations of the c-myc locus differ in different subtypes of Burkitt lymphomas, namely endemic, sporadic BL and AIDS-associated undifferentiated B-cell lymphomas (AIDS-UBL). Chromosomal translocation is also associated with different levels of c-myc expression, and these levels directly correlate with the clonogenic and in vivo tumorigenic properties of BL cells.


Burkitt Lymphoma Chromosomal Breakpoint Small Cell Lung Carcinoma Cell Mouse Plasmacytomas 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Benjamin, D., Magrath, I., Magure, R., Janus, C., Todd, H.D. & Parsons, R.G. (1982) Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt’s and non Burkltt’s type. J Immunol 129: 1336–1342PubMedGoogle Scholar
  2. Croce, C.M. & Nowell, P.C. (1985) Molecular basis of human B cell neoplasia. Blood 65: 1–7PubMedGoogle Scholar
  3. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R.C. & Croce, C.M. (1982) Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79: 7824–7827PubMedCrossRefGoogle Scholar
  4. Dalla-Favera, R., Martinotti, S., Gallo, R.C., Erikson, J. & Croce, C.M. (1983) Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219: 963–967PubMedCrossRefGoogle Scholar
  5. Favrot, M.C., Philip, I., Phillip, T., Dore, J.F. & Lenoir, G.M. (1984) Possible duality in Burkitt lymphoma origin. Lancet i: 745–746Google Scholar
  6. Harris, L.J., Lang, R.B. & Marcu, K.B. (1982) Non-immunoglobulin-associated DNA rearrangements in mouse plasmacytomas. Proc Natl Acad Sci USA 79: 4175–4179PubMedCrossRefGoogle Scholar
  7. Lanfrancone, L., Pelicci, P.G., Cesarman, E. & Dalla-Favera, R. (1984) Mechanisms of oncogene activation in human hemotopoietic tumors. In New Trends in Experimental Hematology, eds. Peschle, C. & Rizzoli, C. ( Serono Symposia, Rome ), pp. 196–203Google Scholar
  8. Leder, P., Battey, J., Lenoir, G., Moulding, C., Murphy, W., Potter, H., Steward, T. & Taub, R. (1983) Translocations among antibody genes in human cancer. Science 222: 765–771PubMedCrossRefGoogle Scholar
  9. Little, C.D., Nau, M.N., Carney, D.N., Gazdar, A.F. & Minna, J.D. (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (London) 306: 194–196CrossRefGoogle Scholar
  10. Rabbits, T.H., Forster, A., Hamlyn, P. & Baer, R. (1984) Effect of somatic mutations within translocated c-myc genes in Burkitt’s lymphomas. Nature (London) 309: 592–597CrossRefGoogle Scholar
  11. Siebenlist, U., Hennighausen, L., Battey, J. & Leder, P. (1984) Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37: 380–390CrossRefGoogle Scholar
  12. Sheng-Ong, G.L.C., Keath, E.J., Piccoli, S.P. & Cole, N.D. (1982) Novel myc oncogene RNA from abortive immunoglobul1n-gene recombination. Cell 31: 443–452CrossRefGoogle Scholar
  13. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S. & Leder, P. (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt’s lymphoma and murine plasmacytomas cells. Proc Natl Acad Sci USA 79: 7837–7841PubMedCrossRefGoogle Scholar
  14. Taub, R., Kelly, K., Battey, J., Latt, S., Lenoir, G.M., Tantravaki, Y., Tu, Z. & Leder, P. (1984) A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell 37: 511–520PubMedCrossRefGoogle Scholar
  15. Wilman, K. G., Clarkson, B., Hayday, A.C. Saito, M., Tonegawa, S. & Hayward, W. S. (1984) Activation of a translocated c-myc gene: role of structural alteration in the upstream region. Proc Natl Acad Sci USA 81: 6798–6802Google Scholar
  16. Ziegler, J. L., et. al. (1984) Non-Hodgkin’s lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Eng J Med 311: 565–570CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • Luisa Lanfrancone
    • 1
  • Pier-Giuseppe Pelicci
    • 1
  • Riccardo Dalla-Favera
    • 1
  1. 1.Dept. of Pathology and Kaplan Cancer CenterNew York University School of MedicineNew YorkUSA

Personalised recommendations